Cancer Survivorship During COVID-19: Optimizing Care and Quality of Life

In the midst of the COVID-19 pandemic, cancer survivors face heightened physical and psychosocial challenges, as well as barriers to health care delivery. The authors of an editorial recently published in the Journal of Cancer Survivorship have provided specific suggestions as to how health care workers involved in cancer care can help to address cancer survivors' needs during this difficult time."The recent COVID-19 pandemic has affected the world and has the potential to disproportionately aff...
Continue reading

Myelodysplastic Syndromes: FDA Approves Luspatercept-aamt for Anemia

Patients with anemia and lower-risk myelodysplastic syndromes (MDS) are usually treated with erythropoiesis-stimulating agent therapy; however, this treatment method is not always effective in this patient population, and many rely on blood transfusions to treat MDS-related anemia. But now with the recent FDA approval of luspatercept-aamt (Reblozyl®, Celgene Corporation), those patients may no longer be dependent on blood transfusions.Luspatercept-aamt was recently FDA approved for the treatment...
Continue reading

Increased COVID-19 Risk in Patients With Cancer

Patients with cancer are at increased risk of infection with severe adult respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19, according to a medical records review of patients with cancer at a hospital in Wuhan, China."Patients with cancer from the epicenter of a viral epidemic harbored a higher risk of SARS-CoV-2 infection… compared with the community. However, fewer than half of these infected patients were undergoing active treatment for their cancers," note the investigat...
Continue reading

Advanced Esophageal Cancer: High Risk of Venous Thromboembolic Events During Preoperative Therapy

An exploratory analysis of data from a phase 3 trial observed a high incidence of venous thromboembolic events (VTEs) in patients with locally advanced resectable esophageal cancer undergoing preoperative chemotherapy and chemoradiotherapy, especially in patients with adenocarcinoma.The occurrence of VTEs, including deep vein thrombosis and pulmonary embolus, can negatively impact the clinical outcomes of patients receiving cancer treatment, reducing quality of life and increasing the risk of mo...
Continue reading

Body Image Dissatisfaction in Patients With Primary Brain Tumors

A new study reports that nearly a third of patients with primary brain tumors experience clinically significant body image dissatisfaction, which can negatively impact their quality of life and psychosocial well-being.Body image—a concept consisting of cognitive, emotional, and relational elements derived from one's physical appearance—plays an important role in an individual's self-esteem, relationships, and outlook on life. Due to the physical impacts of treatment, patients with cancer face an...
Continue reading

Copyright © 2020 i3 Health. All rights reserved.